NorthWest Biotherapeutics Inc (NWBO)

[ahp123]

A non-dilution funding without a partnership is more unlikely than a buyout with the expenses the company will have next year or two. Of course, that sounds very good with a funding non-dilution, but it's unrealistic to get more millions without any kind of dilution or partner. But you're right in the rest, hopefully, there could also be other reasons for the long trial .. eg the endpoints and the flaws of design .. but you might be right .. one thing I surely agree with is that we have a much longer wait ahead than most people in here expect. I hope i am wrong to bw